Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 59 | 2024 | 1021 | 5.540 |
Why?
|
| Heart Failure | 44 | 2024 | 2285 | 3.190 |
Why?
|
| Heart Transplantation | 12 | 2024 | 855 | 1.290 |
Why?
|
| Prosthesis Implantation | 9 | 2019 | 141 | 0.830 |
Why?
|
| Shock, Cardiogenic | 8 | 2022 | 193 | 0.730 |
Why?
|
| Thrombosis | 2 | 2022 | 521 | 0.680 |
Why?
|
| Ventricular Function, Left | 6 | 2022 | 506 | 0.630 |
Why?
|
| Heart Valve Prosthesis Implantation | 5 | 2022 | 436 | 0.590 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 643 | 0.560 |
Why?
|
| Heart Ventricles | 10 | 2021 | 762 | 0.500 |
Why?
|
| Retrospective Studies | 38 | 2024 | 16335 | 0.490 |
Why?
|
| Tissue and Organ Procurement | 3 | 2023 | 224 | 0.450 |
Why?
|
| Postoperative Complications | 8 | 2020 | 3071 | 0.420 |
Why?
|
| Waiting Lists | 4 | 2023 | 227 | 0.420 |
Why?
|
| Treatment Outcome | 28 | 2024 | 12356 | 0.420 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2021 | 366 | 0.400 |
Why?
|
| Percutaneous Coronary Intervention | 3 | 2022 | 254 | 0.380 |
Why?
|
| Humans | 77 | 2024 | 124725 | 0.370 |
Why?
|
| Middle Aged | 40 | 2024 | 26797 | 0.370 |
Why?
|
| Hemodynamics | 7 | 2021 | 849 | 0.340 |
Why?
|
| Device Removal | 4 | 2021 | 221 | 0.340 |
Why?
|
| Aortic Valve Insufficiency | 3 | 2019 | 143 | 0.320 |
Why?
|
| Thoracic Surgical Procedures | 2 | 2023 | 102 | 0.310 |
Why?
|
| Tachycardia, Ventricular | 2 | 2024 | 192 | 0.310 |
Why?
|
| Catheter Ablation | 2 | 2024 | 236 | 0.300 |
Why?
|
| Aged | 28 | 2024 | 19764 | 0.300 |
Why?
|
| Male | 48 | 2024 | 61269 | 0.290 |
Why?
|
| Incidental Findings | 1 | 2009 | 126 | 0.290 |
Why?
|
| Heart, Artificial | 2 | 2018 | 69 | 0.270 |
Why?
|
| Myocarditis | 2 | 2018 | 130 | 0.260 |
Why?
|
| Angioplasty, Balloon, Coronary | 5 | 2009 | 181 | 0.250 |
Why?
|
| Registries | 6 | 2022 | 1434 | 0.250 |
Why?
|
| Aorta | 2 | 2020 | 541 | 0.240 |
Why?
|
| Time Factors | 14 | 2024 | 6308 | 0.240 |
Why?
|
| Heart Defects, Congenital | 3 | 2024 | 1815 | 0.240 |
Why?
|
| Physicians | 2 | 2024 | 581 | 0.230 |
Why?
|
| Female | 44 | 2024 | 66569 | 0.230 |
Why?
|
| Heart Valve Diseases | 2 | 2019 | 173 | 0.230 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2021 | 626 | 0.230 |
Why?
|
| Multiple Organ Failure | 1 | 2006 | 141 | 0.230 |
Why?
|
| Cardiomyopathies | 2 | 2021 | 492 | 0.230 |
Why?
|
| Acute Kidney Injury | 3 | 2022 | 636 | 0.230 |
Why?
|
| Aorta, Thoracic | 1 | 2009 | 531 | 0.220 |
Why?
|
| Survival Rate | 9 | 2020 | 2047 | 0.220 |
Why?
|
| Adult | 23 | 2024 | 29488 | 0.210 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2020 | 1116 | 0.200 |
Why?
|
| Equipment Failure | 3 | 2018 | 121 | 0.190 |
Why?
|
| Kidney | 3 | 2024 | 1358 | 0.190 |
Why?
|
| Aortic Valve Stenosis | 1 | 2006 | 334 | 0.190 |
Why?
|
| Hyponatremia | 1 | 2022 | 72 | 0.180 |
Why?
|
| Aortic Valve | 4 | 2013 | 443 | 0.180 |
Why?
|
| Tissue Donors | 2 | 2023 | 494 | 0.180 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2020 | 225 | 0.180 |
Why?
|
| Proportional Hazards Models | 6 | 2020 | 1356 | 0.180 |
Why?
|
| Glucosides | 1 | 2021 | 47 | 0.180 |
Why?
|
| Anticoagulants | 2 | 2022 | 592 | 0.170 |
Why?
|
| Benzhydryl Compounds | 1 | 2021 | 66 | 0.170 |
Why?
|
| Nephrology | 1 | 2022 | 145 | 0.170 |
Why?
|
| Pulmonary Artery | 2 | 2021 | 442 | 0.170 |
Why?
|
| Health Literacy | 1 | 2021 | 82 | 0.170 |
Why?
|
| Plasmapheresis | 1 | 2019 | 28 | 0.170 |
Why?
|
| Renal Replacement Therapy | 1 | 2021 | 142 | 0.160 |
Why?
|
| Cause of Death | 2 | 2018 | 474 | 0.160 |
Why?
|
| Heart Arrest, Induced | 1 | 2020 | 75 | 0.160 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2024 | 1037 | 0.160 |
Why?
|
| Patient Selection | 2 | 2020 | 695 | 0.160 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2019 | 16 | 0.160 |
Why?
|
| Heart Valves | 1 | 2019 | 51 | 0.150 |
Why?
|
| Prosthesis Failure | 2 | 2017 | 158 | 0.150 |
Why?
|
| Incidence | 7 | 2020 | 3142 | 0.150 |
Why?
|
| Survival Analysis | 5 | 2022 | 1499 | 0.150 |
Why?
|
| Blood Pressure Monitors | 1 | 2018 | 3 | 0.150 |
Why?
|
| Transducers, Pressure | 1 | 2018 | 12 | 0.150 |
Why?
|
| Hypoalbuminemia | 1 | 2018 | 18 | 0.150 |
Why?
|
| Transplant Recipients | 1 | 2020 | 217 | 0.150 |
Why?
|
| Renal Insufficiency | 1 | 2021 | 236 | 0.150 |
Why?
|
| Myocardial Ischemia | 1 | 2021 | 340 | 0.150 |
Why?
|
| Arterial Switch Operation | 1 | 2018 | 22 | 0.150 |
Why?
|
| Risk Factors | 12 | 2024 | 10286 | 0.150 |
Why?
|
| Heart | 1 | 2023 | 710 | 0.150 |
Why?
|
| Serum Albumin | 1 | 2018 | 110 | 0.150 |
Why?
|
| International Normalized Ratio | 1 | 2018 | 41 | 0.150 |
Why?
|
| Ventricular Function | 2 | 2019 | 91 | 0.150 |
Why?
|
| Heparin | 1 | 2019 | 226 | 0.150 |
Why?
|
| Sternotomy | 1 | 2018 | 42 | 0.150 |
Why?
|
| Organ Transplantation | 1 | 2020 | 167 | 0.150 |
Why?
|
| Obesity | 3 | 2018 | 2245 | 0.150 |
Why?
|
| Nervous System Diseases | 2 | 2018 | 375 | 0.140 |
Why?
|
| Decision Making | 2 | 2024 | 655 | 0.140 |
Why?
|
| Thrombocytopenia | 1 | 2019 | 221 | 0.140 |
Why?
|
| Vascular Resistance | 1 | 2018 | 186 | 0.140 |
Why?
|
| Prealbumin | 1 | 2017 | 27 | 0.140 |
Why?
|
| Body Size | 1 | 2017 | 55 | 0.140 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 2895 | 0.140 |
Why?
|
| Prosthesis-Related Infections | 1 | 2019 | 177 | 0.130 |
Why?
|
| Reoperation | 1 | 2020 | 833 | 0.130 |
Why?
|
| Nutritional Status | 1 | 2018 | 314 | 0.130 |
Why?
|
| Patient-Centered Care | 1 | 2018 | 224 | 0.130 |
Why?
|
| Cardiology | 1 | 2021 | 504 | 0.130 |
Why?
|
| End Stage Liver Disease | 1 | 2018 | 181 | 0.120 |
Why?
|
| Eosinophilia | 1 | 2017 | 101 | 0.120 |
Why?
|
| Informed Consent | 1 | 2018 | 334 | 0.120 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 292 | 0.120 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2017 | 212 | 0.120 |
Why?
|
| Texas | 6 | 2019 | 3585 | 0.120 |
Why?
|
| Malnutrition | 1 | 2017 | 205 | 0.110 |
Why?
|
| Equipment Design | 5 | 2021 | 596 | 0.110 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2017 | 459 | 0.110 |
Why?
|
| Cell-Derived Microparticles | 1 | 2014 | 30 | 0.110 |
Why?
|
| Transposition of Great Vessels | 1 | 2015 | 130 | 0.110 |
Why?
|
| Coronary Thrombosis | 1 | 2013 | 34 | 0.110 |
Why?
|
| Antithrombins | 1 | 2013 | 56 | 0.100 |
Why?
|
| Prognosis | 5 | 2021 | 4627 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1102 | 0.100 |
Why?
|
| Young Adult | 7 | 2024 | 9023 | 0.100 |
Why?
|
| Fontan Procedure | 1 | 2015 | 182 | 0.100 |
Why?
|
| Recovery of Function | 3 | 2019 | 443 | 0.100 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 437 | 0.090 |
Why?
|
| Follow-Up Studies | 5 | 2024 | 5161 | 0.090 |
Why?
|
| Atrial Fibrillation | 1 | 2018 | 659 | 0.090 |
Why?
|
| Robotics | 2 | 1992 | 108 | 0.090 |
Why?
|
| Aortography | 2 | 2009 | 199 | 0.090 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2009 | 163 | 0.090 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2012 | 155 | 0.090 |
Why?
|
| Wounds and Injuries | 1 | 2013 | 372 | 0.080 |
Why?
|
| United States | 6 | 2023 | 10899 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2013 | 779 | 0.080 |
Why?
|
| Risk Assessment | 5 | 2019 | 3447 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 1952 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2009 | 370 | 0.080 |
Why?
|
| Prosthesis Design | 3 | 2018 | 679 | 0.080 |
Why?
|
| Preoperative Period | 2 | 2018 | 89 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 219 | 0.070 |
Why?
|
| Echocardiography | 4 | 2017 | 1052 | 0.070 |
Why?
|
| Intra-Aortic Balloon Pumping | 2 | 2022 | 43 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 1017 | 0.060 |
Why?
|
| Takayasu Arteritis | 1 | 2006 | 13 | 0.060 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2006 | 18 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 2092 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 1992 | 1758 | 0.060 |
Why?
|
| Coronary Stenosis | 1 | 2006 | 76 | 0.060 |
Why?
|
| Attitude | 1 | 2024 | 115 | 0.050 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2024 | 74 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 1435 | 0.050 |
Why?
|
| Policy | 1 | 2023 | 35 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 2156 | 0.050 |
Why?
|
| Phenylephrine | 1 | 2022 | 38 | 0.050 |
Why?
|
| Stents | 2 | 2006 | 890 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 790 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2006 | 674 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 275 | 0.050 |
Why?
|
| Logistic Models | 2 | 2018 | 1812 | 0.050 |
Why?
|
| Cardiac Tamponade | 1 | 2002 | 36 | 0.050 |
Why?
|
| Pharmacogenomic Testing | 1 | 2021 | 37 | 0.050 |
Why?
|
| Fatal Outcome | 2 | 2018 | 356 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2022 | 6147 | 0.050 |
Why?
|
| Tracheostomy | 1 | 2023 | 192 | 0.040 |
Why?
|
| Heart Neoplasms | 1 | 2002 | 101 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2024 | 441 | 0.040 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 2 | 1990 | 35 | 0.040 |
Why?
|
| Pharmacogenetics | 1 | 2021 | 184 | 0.040 |
Why?
|
| Constriction | 1 | 2020 | 50 | 0.040 |
Why?
|
| Sex Factors | 1 | 2024 | 1287 | 0.040 |
Why?
|
| Arteriovenous Malformations | 1 | 2020 | 47 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 6548 | 0.040 |
Why?
|
| Motivation | 1 | 2021 | 316 | 0.040 |
Why?
|
| Biomarkers | 2 | 2018 | 3067 | 0.040 |
Why?
|
| Diastole | 1 | 2019 | 170 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2023 | 1027 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2018 | 1563 | 0.040 |
Why?
|
| Adolescent | 3 | 2024 | 19284 | 0.040 |
Why?
|
| Ventricular Function, Right | 1 | 2018 | 110 | 0.040 |
Why?
|
| Base Sequence | 5 | 1994 | 3090 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2018 | 152 | 0.030 |
Why?
|
| Punctures | 1 | 2017 | 55 | 0.030 |
Why?
|
| Comorbidity | 2 | 2016 | 1531 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1640 | 0.030 |
Why?
|
| Morbidity | 1 | 2017 | 247 | 0.030 |
Why?
|
| Molecular Sequence Data | 5 | 1994 | 3877 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 307 | 0.030 |
Why?
|
| Heart Valve Prosthesis | 1 | 2019 | 301 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2022 | 852 | 0.030 |
Why?
|
| Deoxyribonucleotides | 1 | 1994 | 10 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2021 | 1002 | 0.030 |
Why?
|
| Melanoma | 1 | 2002 | 835 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 3556 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 1178 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2015 | 337 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 1992 | 1586 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1991 | 369 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 2018 | 436 | 0.030 |
Why?
|
| Hirudins | 1 | 2013 | 37 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 1237 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 590 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 1233 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 873 | 0.020 |
Why?
|
| Bacteriophage M13 | 1 | 1992 | 18 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1992 | 46 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 3432 | 0.020 |
Why?
|
| Myocardium | 1 | 2017 | 997 | 0.020 |
Why?
|
| DNA | 2 | 1994 | 1597 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 797 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 1991 | 107 | 0.020 |
Why?
|
| Quality of Life | 1 | 2021 | 1935 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2014 | 1259 | 0.020 |
Why?
|
| Exons | 2 | 1990 | 796 | 0.020 |
Why?
|
| Lesch-Nyhan Syndrome | 1 | 1990 | 11 | 0.020 |
Why?
|
| Stroke | 1 | 2018 | 986 | 0.020 |
Why?
|
| Nucleotide Mapping | 1 | 1990 | 17 | 0.020 |
Why?
|
| DNA, Viral | 1 | 1992 | 480 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 1390 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 1391 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1991 | 1079 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 4806 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 1991 | 812 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1990 | 647 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2009 | 488 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2009 | 760 | 0.020 |
Why?
|
| Ventricular Dysfunction | 1 | 2006 | 25 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2006 | 93 | 0.020 |
Why?
|
| Subclavian Artery | 1 | 2006 | 74 | 0.020 |
Why?
|
| Genome, Human | 1 | 1991 | 1273 | 0.010 |
Why?
|
| Fluoroscopy | 1 | 2005 | 91 | 0.010 |
Why?
|
| Sheep | 1 | 2005 | 219 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2006 | 441 | 0.010 |
Why?
|
| Myocardial Revascularization | 1 | 2004 | 103 | 0.010 |
Why?
|
| Child | 1 | 2022 | 24383 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2008 | 1352 | 0.010 |
Why?
|
| Pericardial Effusion | 1 | 2002 | 65 | 0.010 |
Why?
|
| Heart Atria | 1 | 2002 | 316 | 0.010 |
Why?
|
| Genes | 2 | 1990 | 445 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2002 | 975 | 0.010 |
Why?
|
| Templates, Genetic | 1 | 1994 | 97 | 0.010 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1994 | 80 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 4342 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1994 | 291 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1994 | 342 | 0.010 |
Why?
|
| Fluorescence | 1 | 1991 | 95 | 0.010 |
Why?
|
| Chromosomes, Human | 1 | 1991 | 130 | 0.010 |
Why?
|
| X Chromosome | 1 | 1991 | 338 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1990 | 101 | 0.010 |
Why?
|
| Fluorometry | 1 | 1990 | 27 | 0.010 |
Why?
|
| Genetic Carrier Screening | 1 | 1990 | 68 | 0.010 |
Why?
|
| Automation | 1 | 1990 | 63 | 0.010 |
Why?
|
| Heterozygote | 1 | 1991 | 671 | 0.000 |
Why?
|
| Pedigree | 1 | 1990 | 1605 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1990 | 2704 | 0.000 |
Why?
|
| Software | 1 | 1990 | 683 | 0.000 |
Why?
|
| Animals | 1 | 2005 | 34024 | 0.000 |
Why?
|